Filing Flows › Fortress Biotech (FBIO) › How it makes money
How Fortress Biotech (FBIO) makes money
Fortress Biotech (FBIO) made $18.7M of revenue in the second quarter 2026 (Q2 2026), +25% from a year earlier. Journey brought in $18.5M (99%); Fortress brought in $208K (1%).
Drawing the Sankey…
Revenue by segment, Q2 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Journey | $18.5M | 98.9% | — | +23% |
| Fortress | $208K | 1.1% | — | — |
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $18.7M | 100.0% |
| Income tax | $320K | 1.7% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $18.7M | +14% |
| Q1 2026 | $16.0M | +22% |
| Q4 2025 | $16.1M | +6% |
| Q3 2025 | $17.6M | +20% |
| Q2 2025 | $16.4M | +10% |
| Q1 2025 | $13.1M | +0.8% |
| Q4 2024 | $15.1M | -24% |
From Fortress Biotech's 10-Q filed Aug 13, 2026 (on EDGAR).
Questions
How does Fortress Biotech make money?
Fortress Biotech (FBIO) made $18.7M of revenue in the second quarter 2026 (Q2 2026), +25% from a year earlier. Journey brought in $18.5M (99%); Fortress brought in $208K (1%).
What is Fortress Biotech's biggest business?
Journey: $18.5M in the second quarter 2026, 99% of revenue, +23% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.